WHF $11.79 -0.0805%
AUGX $3.74 -5.9194%
INFE.PA $50.00 0%
NM $1.75 -0.8523%
NUSI $19.90 -0.2627%
AGBAR $0.55 0%
0353.HK $0.51 2%
0628.HK $0.12 -0.8403%
8371.HK $1.42 -1.3889%
JWN $14.58 -3.6352%
0UWL.L $14.45 -4.5575%
HOME.MC $9.00 -1.0989%
KE $22.07 -2.2153%
SVCT.L $90.50 17.5325%
LECO $166.82 -0.1257%
RMV.L $560.20 -1.1644%
VOSO $14.51 0%
0676.HK $0.69 -1.4286%
UVDV $9.14 -0.5981%
TLOU.L $2.20 -4.3478%
SLG $21.25 -1.4835%
SCLP.L $15.75 -1.5625%
NR $3.81 -0.6527%
AIR $51.69 -1.4114%
IWML $14.43 -2.0918%
9995.HK $39.45 -1.9876%
PPI $24.33 -0.2721%
JRVR $21.37 -1.0648%
DRTS $3.88 0.6494%
SIR.L $461.00 0%
L $58.04 -0.6164%
FLXK.L $30.04 -0.2076%
XDNS.L $1 153.50 1.007%
AGIO $25.37 -0.0591%
0784.HK $0.15 5.036%
IKA.L $48.50 0%
PAYX $106.04 -0.5347%
KTF $8.65 -0.037%
VALD.PA $90.13 -0.144%
EUSB $43.16 -0.3923%
CCRD $23.72 0.5299%
9990.HK $4.24 -0.9346%
3396.HK $8.20 -0.3645%
OSTRW $0.00 0%
0KBK.L $92.22 1.7005%
TCAP.L $169.40 -0.1768%
EIGR $1.04 -7.9646%
SIXA $33.07 -0.1248%
CLSC $19.31 -0.2294%
HPLTU $10.29 0.4883%
0QPJ.L $68.14 0.2643%
BRK.L $1 935.00 0.5195%
RRD $10.84 0%
ALJXR.PA $0.01 2.9412%
VRE.L $18.45 0%
0R2J.L $79.89 0.4152%
TWLVU $10.27 0.035%
NCA.L $67.00 0%
XT0D.L $54.96 0.0637%
SRC $38.09 -0.962%
ZROZ $92.06 -0.4837%
CEM $31.71 0.622%
EDOC.L $9.17 0.7307%
CERE $31.51 -0.0634%
SLRC $13.55 -1.9537%
PIC.BR $66.00 0%
AUAD.L $1 777.00 0.7227%
MGOAX $8.52 -0.5834%
IDW $0.44 -0.2258%
APPH $0.47 -5.2909%
OMU.L $46.45 1.9759%
VALU $45.61 -1.1058%
LIFE $2.35 0.2137%
IVPB.L $128.46 -3.7726%
GLDA.L $6 415.50 0.0312%
ALGEC.PA $0.00 0%
USOU $23.27 0%
0085.HK $1.18 -3.2787%
TND.L $232.40 -3.1667%
BIOC $0.25 1.1124%
SCHD $69.67 -0.3432%
1782.HK $2.30 5.0228%
TS0U.SI $0.33 1.5385%
FEXDR $0.15 0%
CEI $1.16 -4.0496%
CORR-PA $5.70 -1.2149%
IUVL.L $7.88 0.0317%
1104.HK $1.00 -4.7619%
BSML $25.20 0%
CAMP $1.67 -2.9128%
ASDV.L $41.48 0.4115%
8042.HK $0.09 0%
IYH $277.69 -0.5481%
CTRE $19.64 -1.4802%
LCFE.L $0.93 -0.8524%
VULC3.SA $14.47 -2.2297%
GYRO $8.60 0%
UYG $40.95 -1.1586%
IDWP.L $22.10 -0.6296%
GSMGW $0.01 10.5769%
Eng
Логотип
Eng
Лого

GenSight Biologics S.A. SIGHT.PA

$0.93

-$0.04 (-4.22%)
На 18:01, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    44869658.00000000

  • week52high

    4.59

  • week52low

    0.48

  • Revenue

    5276000

  • P/E TTM

    -1

  • Beta

    2.20648800

  • EPS

    -0.15000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    26 июл 2023 г. в 05:30

Описание компании

GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company also develops products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. GenSight Biologics S.A. was incorporated in 2012 and is headquartered in Paris, France.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек